Correlation between elevated serum ferritin and HbA1c in type 2 diabetes mellitus

Sumesh Raj, G. V. Rajan

Abstract


Background: Serum Ferritin, an acute phase reactant is a marker of iron stores in the body. Recent studies indicate that increased body iron stores and subclinical hemochromatosis has been associated with the development of glucose intolerance, type 2 diabetes, metabolic syndrome and possibly the development of diabetic retinopathy, nephropathy and vascular dysfunction. This study was carried out to examine and establish a relationship between Serum Ferritin with Type 2 diabetes mellitus and metabolic syndrome and to examine whether a correlation between S. ferritin and FBS, HbA1c exists.

Methods: 86 type 2 diabetes subjects (M:F - 57:29, mean age 54.3±9.2 years, mean BMI 24.28kg/m2) which included 24 patients with metabolic syndrome were studied and compared with controls. S. ferritin, Hb, ESR, FBS, PPBS, HbA1c and fasting lipid profile were measured.

Results: Serum ferritin was significantly higher in diabetic patients when compared to controls and serum ferritin had a positive correlation with increasing duration of diabetes.

Conclusions: There was a positive correlation between serum ferritin and FBS, HbA1c. There was no correlation between serum ferritin and age, sex, metabolic syndrome, coexistent hypertension, total cholesterol, LDL and serum triglycerides.

 


Keywords


Ferritin, Diabetes, FBS

Full Text:

PDF

References


Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 2004;291:711-7.

Thomas MC, MacIsaac RJ, Tsalamandris C, Jerums G. Elevated iron indices in patients with diabetes. Diabet Med 2004;21:798-802.

Sharifi F, Sazandeh SH. Serum ferritin in type 2 diabetes and its relationship with HbA1c. Acta Med Iran 2004;42:142-5.

Ford ES, Cogswell ME. Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care 1999;22:1978-83.

Kaye TB, Guay AT, Simonson DC. Non-insulin-dependent diabetes mellitus and elevated serum ferritin level. J Diabetes Complications 1993;7:246-9.

Gallou G, Guilhem I, Poirier JY, Ruelland A, Legras B, Cloarec L. Increased serum ferritin in insulin-dependent diabetes mellitus: relation to glycemic control. Clin Chem 1994;40:947-8.

Kim NH. Serum ferritin in healthy subjects and type 2 diabetes mellitus. Med Korea 2000;41:387-92.

Eshed I, Elis A, Lishner M. Plasma ferritin and type 2 diabetes mellitus. Endocr Res 2001;27:91-7.

Moczulski DK, Grzeszczak W, Gawlik B. Role of hemochromatosis C282Y and H63D mutations in HFE gene in development of type 2 diabetes and diabetic nephropathy. Diabetes Care 2001;24:1187-91.

Fernández-Real JM, Peñarroja G, Castro A, García-Bragado F, López-Bermejo A, Ricart W. Blood letting in high ferritin type 2 diabetes: effects on vascular reactivity. Diabetes Care 2002;25:2249-55.

Cantur K Z, Cetinarslay B, Tarkun I, Canturk NZ. Serum ferritin levels in poorly- and well-controlled diabetes mellitus. Endocr Res 2003;29:299-306.

Eschwege E, Saddi R, Wacjman H, Levy R, Thibult N, Duchateau A. Haemoglobin AIc in patients on venesection therapy for haemochromatosis. Diabete Metab 1982;8:137-40.

Wrede CE, Buettner R, Bollheimer LC, Scholmerich J, Palitzsch KD, Hellerbrand C. Association between serum ferritin and the insulin resistance syndrome in a representative population. Eur J Endocrinol 2006;154:333-40.